Raju Prasad sold $2.1M of CRISPR Therapeutics AG (CRSP)

Executed Jan 22, disclosed Jan 26, 4 days later.

Value, as filed

$2.1M

34,972 sh × $60.19

Executed

Jan 22

the trade date, as filed

Disclosed

Jan 26

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Raju Prasad Chief Financial Officer profile →

Raju Prasad (Chief Financial Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $2.1M of CRSP (34,972 sh × $60.19, as filed), executed Jan 22.

The name

CRSP

CRISPR Therapeutics AG CRSP · Healthcare · 34 filings in 24 months ticker →

Healthcare · CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered R…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Raju Prasad in CRSP

CRSPSALE CRISPR Therapeutics AG $173K
3,708 sh × $46.78
Exec Mar 23
Filed Mar 24 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $476K
9,869 sh across 2 lots
Exec Mar 16
Filed Mar 17 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $1.8M
29,700 sh across 3 lots
Exec Jan 6
Filed Jan 8 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $503K
9,000 sh across 2 lots
Exec Dec 22 2025
Filed Dec 23 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $157K
3,762 sh × $41.80
Exec Mar 17 2025
Filed Mar 18 2025 · 5:30 PM ET